Adma Biologics (ADMA) Change in Account Payables (2011 - 2025)
Adma Biologics' (ADMA) quarterly Change in Account Payables came in at -$2.2 million in Q4 2025, down 155.89% YoY from $3.9 million in Q4 2024, and up 54.82% on a QoQ basis from -$4.9 million in Q3 2025.
Adma Biologics (ADMA) Change in Account Payables (2011 - 2025) Analysis & Trends
Adma Biologics (ADMA) has 13 years of Change in Account Payables data on file, last reported at -$2.2 million in Q4 2025.
- Quarterly Change in Account Payables fell 155.89% year-over-year to -$2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (down 43.86% YoY) and the FY2025 annual result came in at $2.3 million, down 43.86% from the prior year.
- Change in Account Payables grew to -$2.2 million in Q4 2025, from -$4.9 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $13.8 million in Q3 2022 to a low of -$12.0 million in Q4 2022.
- A 5-year average of $623750.0 and a median of $66000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables surged 16280.0% — and 2025, when it slumped 401.36%.
- Tracing ADMA's Change in Account Payables over 5 years: stood at -$4.9 million in 2021, then tumbled by 146.61% to -$12.0 million in 2022, then surged by 141.73% to $5.0 million in 2023, then fell by 21.07% to $3.9 million in 2024, then sank by 155.89% to -$2.2 million in 2025.
- The last three Change in Account Payables figures came in at -$2.2 million (Q4 2025), -$4.9 million (Q3 2025), and $9.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.20 Mn |
| Dec 31, 2025 | -2.20 Mn |
| Sep 30, 2025 | -4.88 Mn |
| Sep 30, 2025 | -4.88 Mn |
| Jun 30, 2025 | 9.27 Mn |
| Jun 30, 2025 | 9.27 Mn |
| Mar 31, 2025 | 142,000.00 |
| Mar 31, 2025 | 142,000.00 |
| Dec 31, 2024 | 3.94 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -1.86 Mn |
| Mar 31, 2024 | 447,000.00 |
| Mar 31, 2024 | 447,000.00 |
| Dec 31, 2023 | 4.99 Mn |
| Dec 31, 2023 | 4.99 Mn |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |